Literature DB >> 20584005

Management of anaphylaxis in primary care: Canadian expert consensus recommendations.

S Waserman1, Z Chad, M J Francoeur, P Small, D Stark, T K Vander Leek, A Kaplan, M Kastner.   

Abstract

BACKGROUND: Anaphylaxis is often managed inadequately. We used findings from a systematic review of gaps in anaphylaxis management to develop evidence-based recommendations for gaps rated as clinically important by a panel of Canadian allergy experts.
METHODS: The nominal group technique (NGT) consensus methodology was used to develop evidence-based recommendations for the management of anaphylaxis in primary care. Physician-specific gaps from our systematic review were prioritized by consensus meeting participants in two rounds, which involved the rating, discussion, and re-rating of gaps. Using current anaphylaxis guidelines, recommendations were then developed for each category of gaps that were identified by the panel as clinically important.
RESULTS: Thirty unique physician gaps from the systematic review were categorized according to gaps of knowledge and anaphylaxis practice behaviors. The panel rated diagnosis of anaphylaxis, and when and how to use epinephrine auto-injectors as clinically important knowledge gaps; and rated infrequent or delayed epinephrine administration, low rate of auto-injector prescription, and infrequent or no referrals to allergy specialists after a reaction as important practice behavior gaps. Evidence from four guidelines was used to support the consensus recommendation statements for three resulting categories of gap themes: anaphylaxis management, epinephrine use, and follow-up care.
CONCLUSION: We used an NGT consensus methodology to develop an educational resource for primary care physicians and allergists to better understand how to manage patients with anaphylaxis. Next steps include testing our findings against observed data in primary care settings and to develop other strategies or tools to overcome gaps in anaphylaxis management.

Entities:  

Mesh:

Year:  2010        PMID: 20584005     DOI: 10.1111/j.1398-9995.2010.02418.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  10 in total

1.  Anaphylaxis.

Authors:  Harold Kim; David Fischer
Journal:  Allergy Asthma Clin Immunol       Date:  2011-11-10       Impact factor: 3.406

Review 2.  Systematic review of outcome measures in trials of pediatric anaphylaxis treatment.

Authors:  Tamar Rubin; Jacqueline Clayton; Denise Adams; Hsing Jou; Sunita Vohra
Journal:  BMC Pediatr       Date:  2014-06-20       Impact factor: 2.125

3.  Immediate hypersensitivity reaction following liposomal amphotericin-B (AmBisome) infusion.

Authors:  Proggananda Nath; Ariful Basher; Michiyo Harada; Santana Sarkar; Shahjada Selim; Richard J Maude; Eisei Noiri; Abul Faiz
Journal:  Trop Doct       Date:  2014-08-19       Impact factor: 0.731

4.  Epinephrine auto-injector prescriptions to food-allergic patients in primary care in The Netherlands.

Authors:  Jacquelien Saleh-Langenberg; A E J Dubois; F Groenhof; J W H Kocks; T van der Molen; B M J Flokstra-de Blok
Journal:  Allergy Asthma Clin Immunol       Date:  2015-10-15       Impact factor: 3.406

5.  Anaphylaxis across two Canadian pediatric centers: evaluating management disparities.

Authors:  Alison Ym Lee; Paul Enarson; Ann E Clarke; Sébastien La Vieille; Harley Eisman; Edmond S Chan; Christopher Mill; Lawrence Joseph; Moshe Ben-Shoshan
Journal:  J Asthma Allergy       Date:  2016-12-30

Review 6.  How to manage anaphylaxis in primary care.

Authors:  Alberto Alvarez-Perea; Luciana Kase Tanno; María L Baeza
Journal:  Clin Transl Allergy       Date:  2017-12-11       Impact factor: 5.871

Review 7.  Anaphylaxis.

Authors:  David Fischer; Timothy K Vander Leek; Anne K Ellis; Harold Kim
Journal:  Allergy Asthma Clin Immunol       Date:  2018-09-12       Impact factor: 3.406

Review 8.  Food allergy and anaphylaxis.

Authors:  David Yue; Amanda Ciccolini; Ernie Avilla; Susan Waserman
Journal:  J Asthma Allergy       Date:  2018-06-20

9.  Should steroids be used for anaphylaxis after the COVID-19 vaccine?

Authors:  Youngho Seo; Taekyu Ahn; Jinhui Paik; Soo Kang
Journal:  Clin Exp Emerg Med       Date:  2021-12-31

10.  CSACI position statement: transition recommendations on existing epinephrine autoinjectors.

Authors:  Lucy Dong Xuan Li; Elissa M Abrams; Elana Lavine; Kyla Hildebrand; Douglas Paul Mack
Journal:  Allergy Asthma Clin Immunol       Date:  2021-12-13       Impact factor: 3.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.